Clinical Trial Update: Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma [Phase 2]

View source ↗

Summary

This report summarizes a Phase 2 trial evaluating a multi-agent regimen of methotrexate, procarbazine, lomustine, dexamethasone, and cytarabine in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• CYTARABINE (CYTARABINE)
• DEXAMETHASONE (Dexamethasone)
• Lomustine (Lomustine)
• METHOTREXATE (METHOTREXATE)
• Procarbazine (procarbazine)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Lymphoma | Phase 2 | Status: COMPLETED